Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AKBAAkebia Therapeutics, Inc.

Nasdaq · CIK 0001517022
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts512

Identity from submissions API

NameAkebia Therapeutics, Inc.
CIK0001517022
TickersAKBA
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN208756903
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-871-2098
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
180 THIRD AVENUE
FLOOR 2
WALTHAM
MA
02451
MA
Mailing address
180 THIRD AVENUE
FLOOR 2
WALTHAM
MA
02451
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

887 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K 8-K 1.01,1.02,2.03,3.02,7.01,8.01,9.01 0001517022-26-000089 001-36352 261555599 34 191864 1 1
2026-11-05 10-Q 10-Q 0001517022-26-000084 001-36352 261524832 34 10768212 1 1
2026-11-05 8-K 8-K 2.02 0001517022-26-000083 001-36352 261524758 34 258922 1 1
2026-10-23 8-K 8-K 3.01 0001517022-26-000075 001-36352 261482236 34 149152 1 1
2026-10-14 8-K 8-K 5.02 0001517022-26-000071 001-36352 261458319 34 144842 1 1
2026-08-10 4 PRIMARY DOCUMENT 0001591467-26-000004 8284
2026-08-05 S-8 S-8 0001193125-26-335375 333-298020 261244539 33 321546 1 1
2026-08-05 10-Q 10-Q 0001517022-26-000051 001-36352 261243586 34 10567448 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001517022-26-000050 001-36352 261243540 34 267705 1 1
2026-07-01 4 PRIMARY DOCUMENT 0001762507-26-000004 5245
2026-06-30 8-K 8-K 7.01,8.01,9.01 0001517022-26-000047 001-36352 261138062 34 227980 1 1
2026-06-29 144 xsl144X01/primary_doc.xml 0001517022-26-000044 001-36352 261137674 33 4218
2026-06-22 4 PRIMARY DOCUMENT 0001808317-26-000001 8181
2026-06-22 4 PRIMARY DOCUMENT 0001609480-26-000003 8176
2026-06-22 4 PRIMARY DOCUMENT 0001244159-26-000001 8199
2026-06-22 4 PRIMARY DOCUMENT 0001890219-26-000001 8192
2026-06-22 8-K 8-K 5.07 0001517022-26-000043 001-36352 261107324 34 181683 1 1
2026-06-22 4 PRIMARY DOCUMENT 0001204946-26-000001 8291
2026-06-22 4 PRIMARY DOCUMENT 0001248144-26-000001 8191
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000200 005-88058 26966276 34 7967
2026-05-07 10-Q 10-Q 0001517022-26-000039 001-36352 26950866 34 9711451 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001517022-26-000038 001-36352 26950812 34 270716 1 1
2026-04-29 ARS ARS 0001140361-26-017532 001-36352 26909758 34 2627695
2026-04-28 DEFA14A DEFA14A 0001517022-26-000035 001-36352 26907918 34 440783
2026-04-28 DEF 14A DEF 14A 0001517022-26-000034 001-36352 26907905 34 3582137 1 1
2026-04-15 PRE 14A DEF 14A 0001517022-26-000029 001-36352 26864245 34 3956811 1 1
2026-04-03 4 PRIMARY DOCUMENT 0001635046-26-000005 6042
2026-04-03 3 PRIMARY DOCUMENT 0001635046-26-000004 9578
2026-04-01 8-K 8-K 5.02,9.01 0001517022-26-000024 001-36352 26829085 34 177697 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000566 005-88058 26797554 34 7120
2026-03-05 4 PRIMARY DOCUMENT 0001591467-26-000003 6760
2026-02-26 10-K 10-K 0001517022-26-000020 001-36352 26681725 34 17260973 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001517022-26-000019 001-36352 26681658 34 304899 1 1
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000019 005-88058 26609484 34 7942
2026-02-04 4 PRIMARY DOCUMENT 0002007730-26-000002 7035
2026-02-04 4 PRIMARY DOCUMENT 0001661887-26-000002 7019
2026-02-04 4 PRIMARY DOCUMENT 0001619834-26-000002 8869
2026-02-04 4 PRIMARY DOCUMENT 0002107264-26-000006 15117
2026-02-04 4 PRIMARY DOCUMENT 0001762507-26-000002 5193
2026-02-04 4 PRIMARY DOCUMENT 0001591467-26-000002 13950
2026-02-03 4 PRIMARY DOCUMENT 0001661887-26-000001 7655
2026-02-03 4 PRIMARY DOCUMENT 0001619834-26-000001 7989
2026-02-03 4 PRIMARY DOCUMENT 0002107264-26-000005 7627
2026-02-03 4 PRIMARY DOCUMENT 0002007730-26-000001 7985
2026-02-03 4 PRIMARY DOCUMENT 0001762507-26-000001 7661
2026-02-03 4 PRIMARY DOCUMENT 0001591467-26-000001 8769
2026-02-03 3 PRIMARY DOCUMENT 0002107264-26-000004 12566
2026-02-02 144 xsl144X01/primary_doc.xml 0001517022-26-000013 001-36352 26589268 33 4298
2026-02-02 144 xsl144X01/primary_doc.xml 0001517022-26-000012 001-36352 26589264 33 4298
2026-02-02 144 xsl144X01/primary_doc.xml 0001517022-26-000011 001-36352 26589259 33 4310
2026-02-02 144 xsl144X01/primary_doc.xml 0001517022-26-000010 001-36352 26589255 33 4301
2026-02-02 144 xsl144X01/primary_doc.xml 0001517022-26-000009 001-36352 26589251 33 4265
2026-01-30 8-K 8-K 1.01,2.03,5.02,9.01 0001517022-26-000008 001-36352 26580633 34 387625 1 1
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000635 005-88058 26545888 34 10873
2026-01-12 8-K 8-K 2.02,7.01,9.01 0001517022-26-000003 001-36352 26524752 34 4242306 1 1
2025-12-01 8-K 8-K 1.01,7.01,8.01,9.01 0001517022-25-000051 001-36352 251537126 34 219226 1 1
2025-11-17 8-K 8-K 1.01 0001517022-25-000048 001-36352 251489358 34 159725 1 1
2025-11-10 10-Q 10-Q 0001517022-25-000046 001-36352 251464369 34 10752110 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001517022-25-000045 001-36352 251464277 34 265665 1 1
2025-10-28 8-K 8-K 7.01,8.01,9.01 0001517022-25-000040 001-36352 251425414 34 210128 1 1
2025-08-07 S-8 S-8 0001193125-25-175015 333-289340 251191838 33 278038 1 1
2025-08-07 10-Q 10-Q 0001628280-25-038600 001-36352 251191646 34 10453215 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001517022-25-000034 001-36352 251191542 34 264550 1 1
2025-07-01 4 PRIMARY DOCUMENT 0001562180-25-005201 5194
2025-06-30 144 xsl144X01/primary_doc.xml 0001517022-25-000031 001-36352 251093502 33 4158
2025-06-13 8-K 8-K 5.02,5.07 0001517022-25-000030 001-36352 251044740 34 334473 1 1
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004724 8117
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004723 8001
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004722 7991
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004721 7970
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004720 8015
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004719 7966
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004718 7983
2025-06-11 4 PRIMARY DOCUMENT 0001562180-25-004717 9552
2025-06-05 4 PRIMARY DOCUMENT 0001562180-25-004491 5129
2025-05-08 10-Q 10-Q 0001628280-25-023460 001-36352 25923877 34 9500722 1 1
2025-05-08 8-K 8-K 2.02,9.01 0001517022-25-000027 001-36352 25923806 34 274985 1 1
2025-04-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000479 005-88058 25891952 34 6126
2025-04-29 ARS ARS 0001517022-25-000025 001-36352 25887460 34 25589344
2025-04-29 DEFA14A DEFA14A 0001517022-25-000024 001-36352 25887211 34 426897
2025-04-29 DEF 14A DEF 14A 0001517022-25-000023 001-36352 25887055 34 3570684 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000548 005-88058 25844528 34 10761
2025-03-20 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-25-059327 001-36352 25757152 34 425145 1 1
2025-03-20 424B5 424B5 0001193125-25-059312 333-281903 25757102 33 617389
2025-03-19 424B5 424B5 0001193125-25-057843 333-281903 25752885 33 615509
2025-03-13 10-K 10-K 0001628280-25-012470 001-36352 25733831 34 13325909 1 1
2025-03-13 8-K 8-K 2.02,9.01 0001517022-25-000017 001-36352 25733817 34 294082 1 1
2025-03-04 4 PRIMARY DOCUMENT 0001562180-25-001998 8045
2025-03-04 4 PRIMARY DOCUMENT 0001562180-25-001997 5163
2025-03-03 144 xsl144X01/primary_doc.xml 0001517022-25-000012 001-36352 25699890 33 4716
2025-03-03 144 xsl144X01/primary_doc.xml 0001517022-25-000011 001-36352 25699868 33 4805
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895345-25-000072 005-88058 25630550 34 6611
2025-02-07 8-K 8-K 1.01,2.03,3.02 0001517022-25-000010 001-36352 25599371 34 173094 1 1
2025-02-04 4 PRIMARY DOCUMENT 0001562180-25-000917 17612
2025-02-04 4 PRIMARY DOCUMENT 0001562180-25-000916 11733
2025-02-04 4 PRIMARY DOCUMENT 0001562180-25-000915 9850
2025-02-04 4 PRIMARY DOCUMENT 0001562180-25-000914 9583
2025-02-04 4 PRIMARY DOCUMENT 0001562180-25-000913 7651
2025-02-03 144 xsl144X01/primary_doc.xml 0001517022-25-000007 001-36352 25584094 33 4126
2025-02-03 144 xsl144X01/primary_doc.xml 0001517022-25-000006 001-36352 25584073 33 4118
2025-02-03 144 xsl144X01/primary_doc.xml 0001517022-25-000005 001-36352 25584041 33 4211
2025-01-30 S-8 S-8 0001193125-25-016257 333-284590 25571189 33 153943
2025-01-22 4 PRIMARY DOCUMENT 0001562180-25-000453 6803
2025-01-13 8-K 8-K 7.01,8.01,9.01 0001517022-25-000004 001-36352 25524907 34 3978505 1 1
2024-11-08 SC 13G us00972d1054_110824.txt 0002012383-24-003437 005-88058 241439571 34 13651
2024-11-07 10-Q 10-Q 0001628280-24-045979 001-36352 241433152 34 9511033 1 1
2024-11-07 8-K 8-K 2.02,9.01 0001517022-24-000075 001-36352 241433098 34 271160 1 1
2024-10-22 SC 13G us00972d1054_102224.txt 0002012383-24-001578 005-88058 241387289 34 13637
2024-10-22 8-K 8-K 7.01,9.01 0001517022-24-000070 001-36352 241384725 34 214394 1 1
2024-10-16 8-K 8-K 1.01 0001517022-24-000067 001-36352 241373292 34 166805 1 1
2024-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-12 16:30:00 9999999995-24-002822 333-281903 241296361 33 1715
2024-09-10 CORRESP filename1.htm 0001628280-24-040031 7531
2024-09-09 UPLOAD filename1.pdf 0000000000-24-010161 333-281903 40004
2024-09-03 S-3 S-3 0001628280-24-039115 333-281903 241274098 33 2106026
2024-08-08 10-Q 10-Q 0001628280-24-035879 001-36352 241186116 34 9797066 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001517022-24-000065 001-36352 241185980 34 281000 1 1
2024-07-11 8-K 8-K 1.01,1.02 0001517022-24-000061 001-36352 241110981 34 175764 1 1
2024-07-02 4 PRIMARY DOCUMENT 0001562180-24-005516 7758
2024-06-26 3 PRIMARY DOCUMENT 0001562180-24-005321 6604
2024-06-24 8-K 8-K 5.02 0001517022-24-000059 001-36352 241062225 34 171846 1 1
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004910 7996
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004909 7976
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004907 8021
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004906 7972
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004905 7988
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004904 8122
2024-06-10 4 PRIMARY DOCUMENT 0001562180-24-004901 8007
2024-06-10 8-K 8-K 5.07 0001517022-24-000057 001-36352 241032751 34 42520
2024-05-14 4 PRIMARY DOCUMENT 0001562180-24-004026 5157
2024-05-14 4 PRIMARY DOCUMENT 0001562180-24-004025 5205
2024-05-13 144 xsl144X01/primary_doc.xml 0001517022-24-000052 001-36352 24940968 33 5351
2024-05-13 144 xsl144X01/primary_doc.xml 0001517022-24-000051 001-36352 24940966 33 5301
2024-05-09 4 PRIMARY DOCUMENT 0001562180-24-003948 4668
2024-05-09 10-Q 10-Q 0001628280-24-021945 001-36352 24928499 34 8807843 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001517022-24-000050 001-36352 24928490 34 279411 1 1
2024-04-25 ARS ARS 0001517022-24-000047 001-36352 24877542 34 23718422
2024-04-25 DEFA14A DEFA14A 0001517022-24-000046 001-36352 24877523 34 423689
2024-04-25 DEF 14A DEF 14A 0001517022-24-000045 001-36352 24877511 34 4011831 1 1
2024-04-23 8-K 8-K 2.03 0001517022-24-000035 001-36352 24862777 34 27788
2024-04-16 8-K 8-K 1.01 0001517022-24-000033 001-36352 24846109 34 26992
2024-03-28 8-K 8-K 7.01,8.01,9.01 0001517022-24-000031 001-36352 24793031 34 1349423 1 1
2024-03-15 8-K 8-K 5.02 0001193125-24-069123 001-36352 24754718 34 143349 1 1
2024-03-14 10-K 10-K 0001628280-24-011270 001-36352 24751308 34 14061889 1 1
2024-03-14 8-K 8-K 2.02,9.01 0001517022-24-000029 001-36352 24750415 34 274359 1 1
2024-03-01 4 PRIMARY DOCUMENT 0001562180-24-002023 5020
2024-03-01 4 PRIMARY DOCUMENT 0001562180-24-002022 4971
2024-03-01 4 PRIMARY DOCUMENT 0001562180-24-002021 7856
2024-03-01 4 PRIMARY DOCUMENT 0001562180-24-002020 4973
2024-02-29 4 PRIMARY DOCUMENT 0001562180-24-001995 5161
2024-02-29 4 PRIMARY DOCUMENT 0001562180-24-001994 5021
2024-02-29 4 PRIMARY DOCUMENT 0001562180-24-001993 5163
2024-02-29 4 PRIMARY DOCUMENT 0001562180-24-001992 7856
2024-02-29 144 xsl144X01/primary_doc.xml 0001517022-24-000027 001-36352 24704301 33 5399
2024-02-29 144 xsl144X01/primary_doc.xml 0001517022-24-000026 001-36352 24704235 33 5314
2024-02-29 144 xsl144X01/primary_doc.xml 0001517022-24-000025 001-36352 24704167 33 4756
2024-02-29 144 xsl144X01/primary_doc.xml 0001517022-24-000024 001-36352 24704141 33 4709
2024-02-27 144 xsl144X01/primary_doc.xml 0001517022-24-000023 001-36352 24689091 33 4114
2024-02-27 144 xsl144X01/primary_doc.xml 0001517022-24-000022 001-36352 24689084 33 4164
2024-02-27 144 xsl144X01/primary_doc.xml 0001517022-24-000021 001-36352 24689053 33 4715
2024-02-27 144 xsl144X01/primary_doc.xml 0001517022-24-000020 001-36352 24689037 33 4803
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020210 005-88058 24627312 34 13006
2024-02-13 8-K 8-K 5.02 0001517022-24-000019 001-36352 24622643 34 170871 1 1
2024-02-09 SC 13G/A ff3004412_13ga2-satter.htm 0000895345-24-000039 005-88058 24614619 34 58673
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000983 7709
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000980 7731
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000978 7970
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000975 7632
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000973 7921
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000971 12595
2024-02-02 4 PRIMARY DOCUMENT 0001562180-24-000970 9712
2024-02-01 144 xsl144X01/primary_doc.xml 0001517022-24-000016 001-36352 24587686 33 4207
2024-02-01 144 xsl144X01/primary_doc.xml 0001517022-24-000015 001-36352 24587531 33 4111
2024-01-30 S-8 S-8 0001193125-24-019450 333-276770 24578656 33 114677
2024-01-30 8-K 8-K 1.01,1.02,2.03,3.02 0001517022-24-000014 001-36352 24575914 34 186114 1 1
2024-01-18 3 PRIMARY DOCUMENT 0001562180-24-000541 6562
2024-01-18 3 PRIMARY DOCUMENT 0001562180-24-000527 6594
2024-01-08 8-K 8-K 5.02 0001517022-24-000007 001-36352 24520133 34 175547 1 1
2024-01-08 8-K 8-K 2.02,7.01,9.01 0001517022-24-000004 001-36352 24518413 34 3363160 1 1
2023-12-18 8-K 8-K 1.01 0001517022-23-000046 001-36352 231493751 34 170283 1 1
2023-11-21 8-K 8-K 8.01 0001517022-23-000044 001-36352 231429080 34 170513 1 1
2023-11-08 10-Q 10-Q 0001628280-23-037557 001-36352 231386002 34 9106824 1 1
2023-11-08 8-K 8-K 2.02,9.01 0001517022-23-000042 001-36352 231385971 34 251640 1 1
2023-11-02 8-K 8-K 1.01 0001517022-23-000040 001-36352 231372978 34 173266 1 1
2023-10-25 8-K 8-K 7.01,9.01 0001517022-23-000037 001-36352 231345882 34 1306166 1 1
2023-10-12 8-K 8-K 5.02 0001517022-23-000034 001-36352 231321774 34 172567 1 1
2023-09-26 8-K 8-K 7.01,9.01 0001628280-23-033033 001-36352 231280978 34 1324643 1 1
2023-08-28 10-Q 10-Q 0001628280-23-030698 001-36352 231210530 34 12138194 1 1
2023-08-28 10-K/A 10-K/A 0001628280-23-030697 001-36352 231210523 34 15862390 1 1
2023-08-25 8-K 8-K 2.02,9.01 0001517022-23-000032 001-36352 231203825 34 1461568 1 1
2023-08-17 8-K 8-K 3.01,9.01 0001517022-23-000029 001-36352 231181950 34 196645 1 1
2023-08-11 8-K 8-K 7.01,9.01 0001517022-23-000027 001-36352 231161543 34 1317448 1 1
2023-08-10 NT 10-Q NT 10-Q 0001517022-23-000025 001-36352 231160617 34 45350
2023-08-01 4 PRIMARY DOCUMENT 0001562180-23-006088 7618
2023-08-01 8-K 8-K 5.02 0001517022-23-000023 001-36352 231131655 34 172930 1 1
2023-07-18 3 PRIMARY DOCUMENT 0001562180-23-005953 6495
2023-07-18 8-K 8-K 7.01,8.01,9.01 0001517022-23-000019 001-36352 231093015 34 1309974 1 1
2023-06-13 8-K 8-K 5.02 0001517022-23-000017 001-36352 231010227 34 201062 1 1
2023-06-08 8-K 8-K 5.02,5.07,9.01 0001517022-23-000014 001-36352 231002314 34 211757 1 1
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004960 8041
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004959 7939
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004958 7907
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004957 7915
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004956 7926
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004955 7894
2023-06-08 4 PRIMARY DOCUMENT 0001562180-23-004954 7890
2023-06-07 8-K 8-K 7.01,9.01 0001517022-23-000011 001-36352 23997662 34 1849600 1 1
2023-06-06 S-8 S-8 0001193125-23-161630 333-272453 23996326 33 153967
2023-06-02 8-K 8-K 8.01 0001517022-23-000009 001-36352 23986778 34 192094 1 1
2023-05-31 8-K 8-K 7.01 0001628280-23-020211 001-36352 23978992 34 190935 1 1
2023-05-30 8-K 8-K 7.01,8.01,9.01 0001193125-23-156011 001-36352 23971402 34 190890 1 1
2023-05-25 4 PRIMARY DOCUMENT 0001562180-23-004504 9573
2023-05-25 4 PRIMARY DOCUMENT 0001562180-23-004503 9622
2023-05-25 144 xsl144X01/primary_doc.xml 0001517022-23-000005 001-36352 23961834 33 5207
2023-05-25 144 xsl144X01/primary_doc.xml 0001517022-23-000004 001-36352 23961523 33 5263
2023-05-25 8-K 8-K 1.01,7.01,9.01 0001628280-23-019654 001-36352 23956237 34 1342667 1 1
2023-05-23 8-K 8-K 8.01,9.01 0001193125-23-151132 001-36352 23946541 34 154627 1 1
2023-05-18 4 PRIMARY DOCUMENT 0001562180-23-004254 4960
2023-05-18 4 PRIMARY DOCUMENT 0001562180-23-004253 4961
2023-05-16 144 xsl144X01/primary_doc.xml 0001517022-23-000003 001-36352 23928879 33 5233
2023-05-16 144 xsl144X01/primary_doc.xml 0001517022-23-000002 001-36352 23928506 33 5225
2023-05-16 4 PRIMARY DOCUMENT 0001562180-23-004169 4984
2023-05-16 4 PRIMARY DOCUMENT 0001562180-23-004168 8510
2023-05-09 8-K 8-K 3.01 0001193125-23-139506 001-36352 23903120 34 147444 1 1
2023-05-08 10-Q 10-Q 0001628280-23-016258 001-36352 23895890 34 7884786 1 1
2023-05-08 8-K 8-K 2.02,9.01 0001193125-23-137689 001-36352 23895880 34 213537 1 1
2023-05-08 8-K 8-K 5.07 0001193125-23-137688 001-36352 23895858 34 150532 1 1
2023-04-28 ARS ARS 0001193125-23-125003 001-36352 23861462 34 1538095
2023-04-28 DEF 14A DEF 14A 0001193125-23-124284 001-36352 23861444 34 4544767 1 1
2023-04-28 8-K 8-K 5.03,9.01 0001193125-23-124259 001-36352 23860188 34 275069 1 1
2023-04-25 8-K 8-K 8.01 0001193125-23-115513 001-36352 23845797 34 140490 1 1
2023-04-21 DEFA14A DEFA14A 0001193125-23-110580 001-36352 23836759 34 56782
2023-04-14 DEFA14A DEFA14A 0001193125-23-102245 001-36352 23821939 34 516237
2023-04-14 DEFA14A DEFA14A 0001193125-23-101547 001-36352 23820024 34 24272
2023-04-11 DEFA14A DEFA14A 0001193125-23-097795 001-36352 23813448 34 20428
2023-04-11 8-K 8-K 8.01 0001193125-23-097482 001-36352 23812822 34 140142 1 1
2023-03-31 DEFA14A DEFA14A 0001193125-23-088046 001-36352 23787771 34 24792
2023-03-27 DEFA14A DEFA14A 0001193125-23-080563 001-36352 23765214 34 13724
2023-03-27 DEFA14A DEFA14A 0001193125-23-080560 001-36352 23765164 34 17757
2023-03-27 DEFA14A DEFA14A 0001193125-23-080505 001-36352 23764892 34 2398209
2023-03-24 DEFA14A DEFA14A 0001193125-23-078620 001-36352 23757761 34 29240
2023-03-17 DEFR14A DEFR14A 0001193125-23-073252 001-36352 23740724 34 1117396
2023-03-10 10-K 10-K 0001628280-23-007539 001-36352 23724042 34 15847322 1 1
2023-03-09 8-K 8-K 2.02,9.01 0001193125-23-065311 001-36352 23718213 34 240275 1 1
2023-03-03 4 PRIMARY DOCUMENT 0001562180-23-002201 11388
2023-03-03 4 PRIMARY DOCUMENT 0001562180-23-002200 8500
2023-03-03 4 PRIMARY DOCUMENT 0001562180-23-002199 8502
2023-03-03 4 PRIMARY DOCUMENT 0001562180-23-002198 8550
2023-03-03 4 PRIMARY DOCUMENT 0001562180-23-002197 6710
2023-03-02 8-K 8-K 1.01 0001193125-23-058118 001-36352 23698866 34 140812 1 1
2023-03-01 4 PRIMARY DOCUMENT 0001562180-23-002041 7740
2023-03-01 4 PRIMARY DOCUMENT 0001562180-23-002040 4857
2023-03-01 4 PRIMARY DOCUMENT 0001562180-23-002039 5219
2023-03-01 DEF 14A DEF 14A 0001193125-23-056298 001-36352 23693444 34 751292
2023-03-01 4 PRIMARY DOCUMENT 0001562180-23-002038 4858
2023-03-01 4 PRIMARY DOCUMENT 0001562180-23-002037 5169
2023-02-21 8-K 8-K 8.01,9.01 0001193125-23-042806 001-36352 23645195 34 163387 1 1
2023-02-17 PRE 14A PRE 14A 0001193125-23-042106 001-36352 23643962 34 751873
2023-02-10 SC 13G/A ff1723344_13ga1-satter.htm 0000895345-23-000072 005-88058 23610079 34 58640
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015229 005-88058 23602197 34 12927
2023-02-02 4 PRIMARY DOCUMENT 0001562180-23-000832 13268
2023-02-02 4 PRIMARY DOCUMENT 0001562180-23-000831 7500
2023-02-02 4 PRIMARY DOCUMENT 0001562180-23-000830 7735
2023-01-30 S-8 S-8 0001193125-23-019073 333-269457 23567776 33 116479
2023-01-20 SC 13G/A Akebia_Therapeutics_Inc.txt 0000093751-23-000018 005-88058 23539000 34 8186
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004214 001-36352 23516748 34 7969267 1 1
2022-12-28 8-K 8-K 1.01,1.02,2.05 0001193125-22-313116 001-36352 221491660 34 152492 1 1
2022-12-19 SC 13G ff-1614699_13g-satter.htm 0000895345-22-000827 005-88058 221471171 34 58631
2022-12-15 8-K 8-K 5.02 0001193125-22-305886 001-36352 221464890 34 142492 1 1
2022-12-13 CT ORDER filename1.pdf 20221213,20221213 9999999997-22-004978 001-36352 221458569 34 521751
2022-11-10 8-K 8-K 3.01 0001193125-22-282578 001-36352 221377106 34 142798 1 1
2022-11-08 8-K 8-K 2.05 0001193125-22-280142 001-36352 221368869 34 147181 1 1
2022-11-03 10-Q 10-Q 0001628280-22-028242 001-36352 221358676 34 9461157 1 1
2022-11-03 8-K 8-K 2.02,9.01 0001193125-22-276930 001-36352 221358604 34 234067 1 1
2022-10-07 CT ORDER filename1.pdf 20221007,20221007 9999999997-22-004493 001-36352 221299562 34 161662
2022-09-01 4 PRIMARY DOCUMENT 0001562180-22-006402 5089
2022-08-04 10-Q 10-Q 0001628280-22-021096 001-36352 221137047 34 9792930 1 1
2022-08-04 8-K 8-K 2.02,7.01,9.01 0001193125-22-212531 001-36352 221136756 34 257805 1 1
2022-07-18 8-K 8-K 1.01 0001193125-22-196383 001-36352 221089874 34 143169 1 1
2022-07-08 SC 13G us00972d1054_070822.txt 0000834237-22-010253 005-88058 221075008 34 12209
2022-06-30 8-K 8-K 1.01,1.02 0001193125-22-186174 001-36352 221058152 34 151799 1 1
2022-06-10 4 PRIMARY DOCUMENT 0001562180-22-005001 7474
2022-06-10 8-K 8-K 5.02,5.07 0001193125-22-171529 001-36352 221007663 34 151617 1 1
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004980 11236
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004978 11093
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004977 11080
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004976 11132
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004975 7601
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004974 7618
2022-06-09 4 PRIMARY DOCUMENT 0001562180-22-004973 11110
2022-06-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-069630 005-88058 221005583 34 12927
2022-06-07 4 PRIMARY DOCUMENT 0001562180-22-004870 8303
2022-05-16 4 PRIMARY DOCUMENT 0001562180-22-004031 7396
2022-05-16 4 PRIMARY DOCUMENT 0001562180-22-004030 4946
2022-05-13 8-K 8-K 1.02,3.01 0001193125-22-150303 001-36352 22924156 34 155820 1 1
2022-05-09 10-Q 10-Q 0001628280-22-013318 001-36352 22905139 34 8955007 1 1
2022-05-09 8-K 8-K 2.02,9.01 0001193125-22-144993 001-36352 22905050 34 212765 1 1
2022-04-28 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-061620,2022-04-28 9999999995-22-001129 333-253539 22869767 33 1678
2022-04-28 DEFA14A DEFA14A 0001193125-22-125287 001-36352 22862127 34 849625
2022-04-28 DEF 14A DEF 14A 0001193125-22-125281 001-36352 22862119 34 1464877
2022-04-07 424B5 424B5 0001193125-22-098942 333-253539 22814328 33 457464
2022-04-07 8-K 8-K 1.01,8.01,9.01 0001193125-22-098883 001-36352 22813980 34 449039 1 1
2022-04-07 424B5 424B5 0001193125-22-098875 333-253539 22813957 33 13259
2022-04-07 8-K 8-K 2.05,8.01 0001193125-22-098113 001-36352 22812275 34 149333 1 1
2022-03-30 8-K 8-K 8.01,9.01 0001193125-22-089998 001-36352 22787452 34 165290 1 1
2022-03-18 CT ORDER filename1.pdf 20220318,20220318 9999999997-22-000929 001-36352 22752096 34 161125
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002166 21692
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002165 16662
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002164 12944
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002163 18572
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002162 16470
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002161 18511
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002160 14622
2022-03-01 POS AM POS AM 0001193125-22-061620 333-253539 22699539 33 671647
2022-03-01 10-K 10-K 0001628280-22-004522 001-36352 22698340 34 17856044 1 1
2022-03-01 POSASR POSASR 0001193125-22-061326 333-253539 22698127 33 904078
2022-03-01 8-K 8-K 2.02,9.01 0001193125-22-061300 001-36352 22697890 34 221668 1 1
2022-02-22 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-22-047773 001-36352 22655153 34 186625 1 1
2022-02-18 4/A PRIMARY DOCUMENT 0001562180-22-001654 5931
2022-02-10 SC 13G/A AKEBIA_THERAPEUTICS_INC.txt 0000093751-22-000122 005-88058 22612808 34 8398
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016399 005-88058 22606268 34 12929
2022-02-07 SC 13G/A us00972d1054_020722.txt 0000834237-22-007946 005-88058 22598122 34 13335
2022-01-28 S-8 S-8 0001193125-22-021580 333-262392 22568814 33 110164
2022-01-24 8-K 8-K 5.02 0001193125-22-016101 001-36352 22549953 34 138519 1 1
2022-01-05 4 PRIMARY DOCUMENT 0001562180-22-000236 4874
2021-12-30 CT ORDER filename1.pdf 20211230,20211230 9999999997-21-006044 001-36352 211530610 34 125321
2021-12-15 8-K/A 8-K/A 5.02 0001193125-21-358055 001-36352 211495088 34 146162 1 1
2021-11-04 10-Q 10-Q 0001628280-21-021760 001-36352 211379986 34 9842984 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001193125-21-319374 001-36352 211378125 34 222371 1 1
2021-11-03 4 PRIMARY DOCUMENT 0001562180-21-006801 5449
2021-11-03 3 PRIMARY DOCUMENT 0001562180-21-006800 6490
2021-11-01 8-K 8-K 5.02 0001193125-21-315574 001-36352 211368017 34 142304 1 1
2021-10-01 4 PRIMARY DOCUMENT 0001562180-21-006188 5622
2021-09-28 8-K 8-K 8.01 0001193125-21-285489 001-36352 211286864 34 141494 1 1
2021-09-09 8-K 8-K 7.01,9.01 0001193125-21-268280 001-36352 211243446 34 11190598 1 1
2021-09-02 4 PRIMARY DOCUMENT 0001562180-21-005744 5088
2021-08-24 8-K 8-K 8.01 0001193125-21-254567 001-36352 211198756 34 140779 1 1
2021-08-10 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000380 005-88058 211158458 34 32746
2021-08-05 10-Q 10-Q 0001628280-21-015865 001-36352 211148438 34 9500358 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001193125-21-237047 001-36352 211146420 34 223787 1 1
2021-07-12 SC 13G/A AKEBIA_THERAPEUTICS_INC.txt 0000093751-21-000625 005-88058 211084760 34 10247
2021-06-09 4 PRIMARY DOCUMENT 0001562180-21-004152 5070
2021-06-03 4 PRIMARY DOCUMENT 0001562180-21-004031 11095
2021-06-03 4 PRIMARY DOCUMENT 0001562180-21-004030 11081
2021-06-03 4 PRIMARY DOCUMENT 0001562180-21-004029 11135
2021-06-03 4 PRIMARY DOCUMENT 0001562180-21-004026 11110
2021-06-03 4 PRIMARY DOCUMENT 0001562180-21-004028 11178
2021-06-03 4 PRIMARY DOCUMENT 0001562180-21-004027 11085
2021-06-03 8-K 8-K 5.07 0001193125-21-180654 001-36352 21991246 34 151054 1 1
2021-06-01 8-K 8-K 7.01,8.01,9.01 0001193125-21-177692 001-36352 21982736 34 170154 1 1
2021-05-10 10-Q 10-Q 0001628280-21-009696 001-36352 21907288 34 10545811 1 1
2021-05-10 8-K 8-K 2.02,9.01 0001193125-21-155701 001-36352 21905319 34 209645 1 1
2021-04-22 DEFA14A DEFA14A 0001193125-21-126697 001-36352 21844862 34 883402
2021-04-22 DEF 14A DEF 14A 0001193125-21-126686 001-36352 21844828 34 1304893
2021-04-01 4 PRIMARY DOCUMENT 0001562180-21-002544 4946
2021-04-01 4 PRIMARY DOCUMENT 0001562180-21-002543 4916
2021-04-01 4 PRIMARY DOCUMENT 0001562180-21-002542 4915
2021-04-01 4 PRIMARY DOCUMENT 0001562180-21-002541 4964
2021-04-01 4 PRIMARY DOCUMENT 0001562180-21-002540 9242
2021-04-01 4 PRIMARY DOCUMENT 0001562180-21-002539 4917
2021-03-30 8-K 8-K 7.01,8.01,9.01 0001193125-21-099320 001-36352 21784021 34 162319 1 1
2021-03-18 4 PRIMARY DOCUMENT 0001562180-21-002358 5400
2021-03-18 4 PRIMARY DOCUMENT 0001562180-21-002357 5425
2021-03-18 4 PRIMARY DOCUMENT 0001562180-21-002356 5399
2021-03-18 4 PRIMARY DOCUMENT 0001562180-21-002355 5448
2021-03-18 4 PRIMARY DOCUMENT 0001562180-21-002354 9726
2021-03-18 4 PRIMARY DOCUMENT 0001562180-21-002353 5401
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001787 19317
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001786 12821
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001785 14870
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001784 14930
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001781 12776
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001774 7533
2021-03-02 4 PRIMARY DOCUMENT 0001562180-21-001767 10980
2021-02-25 S-3ASR S-3ASR 0001193125-21-057223 333-253539 21681820 33 1323556
2021-02-25 10-K 10-K 0001628280-21-003283 001-36352 21680196 34 18297473 1 1
2021-02-25 8-K 8-K 2.02,9.01 0001193125-21-055793 001-36352 21676477 34 235512 1 1
2021-02-18 4 PRIMARY DOCUMENT 0001562180-21-001243 5583
2021-02-18 3 PRIMARY DOCUMENT 0001562180-21-001242 6652
2021-02-18 8-K 8-K 5.02 0001193125-21-047118 001-36352 21647703 34 143537 1 1
2021-02-17 8-K 8-K 1.01 0001193125-21-046471 001-36352 21644750 34 148797 1 1
2021-02-12 SC 13G/A SC 13G/A 0001104659-21-021132 005-88058 21622616 34 49728
2021-02-11 SC 13G Akebia_Therapeutics_Inc.txt 0000093751-21-000286 005-88058 21618143 34 10249
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-017368 005-88058 21609967 34 13752
2021-02-10 SC 13G/A AkebiaTherapeuticsInc.txt 0000093751-21-000186 005-88058 21609882 34 10255
2021-02-03 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000057 005-88058 21585484 34 37257
2021-01-29 SC 13G/A us00972d1054_012821.txt 0000834237-21-002871 005-88058 21566873 34 13289
2021-01-28 3 PRIMARY DOCUMENT 0001562180-21-000573 9086
2021-01-28 8-K 8-K 5.02 0001193125-21-020824 001-36352 21565502 34 147733 1 1
2021-01-22 S-8 S-8 0001193125-21-014727 333-252336 21545913 33 90472
2021-01-12 8-K 8-K 7.01,9.01 0001193125-21-006769 001-36352 21522403 34 5565656 1 1
2020-12-15 8-K 8-K 2.03 0001193125-20-317577 001-36352 201388250 34 144014 1 1
2020-12-02 8-K 8-K 1.01 0001193125-20-308391 001-36352 201363968 34 142331 1 1
2020-11-10 SC 13G SEC SCHEDULE 13G 0000902219-20-000435 005-88058 201299763 34 37427
2020-11-05 10-Q 10-Q 0001628280-20-015733 001-36352 201290452 34 12265481 1 1
2020-11-05 8-K 8-K 2.02,9.01 0001193125-20-286276 001-36352 201288807 34 233787 1 1
2020-10-13 SC 13G/A AkebiaTherapeuticsInc.txt 0000093751-20-000964 005-88058 201235982 34 10278
2020-10-09 SC 13G/A NONE 0001567619-20-017709 005-88058 201233151 34 116944
2020-09-25 CT ORDER filename1.pdf 20200925,20200925 9999999997-20-004764 001-36352 201198414 34 125701
2020-09-25 8-K 8-K 8.01 0001193125-20-253955 001-36352 201196830 34 141618 1 1
2020-09-11 8-K 8-K 1.01,9.01 0001193125-20-244225 001-36352 201171613 34 411750 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (512 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 277.66M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
dei EntityPublicFloat Entity Public Float USD 946.38M 2025-06-30 2025 FY 10-K 2026-02-26 0001517022-26-000020
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 227.30M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.54M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.79M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 4.22M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.65M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 57.5 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001517022-26-000034
ffd NetFeeAmt NetFeeAmt USD 351.73 2026-08-03 S-8 2026-08-05 0001193125-26-335375
ffd TtlFeeAmt TtlFeeAmt USD 351.73 2026-08-03 S-8 2026-08-05 0001193125-26-335375
ffd TtlOfferingAmt TtlOfferingAmt USD 2.55M 2026-08-03 S-8 2026-08-05 0001193125-26-335375
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-03 S-8 2026-08-05 0001193125-26-335375
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 26.10M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028609
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 36.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 7.74M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042962
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 987,000 2017-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 102.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 3.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 8.24M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015865
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 926,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042962
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 9.32M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 204.05M 2014-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005335
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.74B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 86.90M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 237,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.80M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.41M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 9.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 2.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 2.70M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023460
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 5.16M 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 8,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014700
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 30.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 3,384 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015733
us-gaap Assets Assets USD 342.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AssetsCurrent Assets, Current USD 220.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 157.47M 2015-09-30 2015 Q3 10-Q 2015-11-09 0001564590-15-010025
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 39.98M 2020-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 76.14M 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 550,000 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 235.41M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) USD 6,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) USD 500,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 225.50M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 1.00M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 227.71M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 20.00M 2021-03-31 2021 Q1 10-Q 2021-05-10 0001628280-21-009696
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 20.00M 2021-03-31 2021 Q1 10-Q 2021-05-10 0001628280-21-009696
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 245,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 245,000 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap AvailableForSaleSecuritiesGrossRealizedGains Available-for-sale Securities, Gross Realized Gains USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions Security 49 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year Security 1 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year Security 49 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 527.75M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 472.70M 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 398,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 100,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045979
us-gaap CapitalizedContractCostNet Capitalized Contract Cost, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 3,939 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 6,369 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 7,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 9,000 2016-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 1,000 2015-09-30 2015 Q3 10-Q 2015-11-09 0001564590-15-010025
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 5,000 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028609
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 5,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 1,000 2016-06-30 2016 Q2 10-Q 2016-08-08 0001564590-16-023285
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 7,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 2,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 159.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 138.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -117.18M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005286
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 149.80M 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 160.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 92.56M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -26.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1.3 2025-07-21 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.41M 2025-07-23 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 27.74M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 277.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 277.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CommonStockValue Common Stock, Value, Issued USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -32.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ContractualObligation Contractual Obligation USD 29.38M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 14.67M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 3.51M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 3.54M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 3.30M 2016-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 3.29M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 3.54M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 824,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 43.30M 2024-06-30 2024 Q2 10-Q 2024-08-08 0001628280-24-035879
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 4.96M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001517022-25-000046
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 30.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ContractWithCustomerRefundLiabilityCurrent Contract with Customer, Refund Liability, Current USD 9.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ContractWithCustomerRefundLiabilityNoncurrent Contract with Customer, Refund Liability, Noncurrent USD 20.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ConvertiblePreferredStockConvertedToOtherSecurities Convertible Preferred Stock Converted to Other Securities USD 4.94M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014700
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 0 2014-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005286
us-gaap CostDirectMaterial Cost, Direct Material USD 18.00M 2021-10-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization USD 29.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 18.61M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021255
us-gaap CostOfGoodsAndServicesSoldAmortization Cost, Amortization USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap CostOfRevenue Cost of Revenue USD 29.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap CustomerRefundLiabilityNoncurrent Customer Refund Liability, Noncurrent USD 40.99M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 52.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 2.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021255
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021760
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 49.94M 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 9,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 49.94M 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 9,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 10.59M 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 194,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 3.01M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap DeferredRevenue Deferred Revenue USD 170.23M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 78.61M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 80.89M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap DeferredSetUpCostsNoncurrent Deferred Set-up Costs, Noncurrent USD 800,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005286
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 15.77M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 413,000 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 4.63M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 383.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 11.87M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 841,000 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2017-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 189,648 2013-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD -81,167 2013-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 289.71M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 22.02M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 799,000 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 7.73M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.24M 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 9.37M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 1.50M 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 382.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 558,935 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 195.42M 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts Deferred Tax Liabilities, Inventory USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0001628280-23-007539
us-gaap DeferredTaxLiabilitiesDerivatives Deferred Tax Liabilities, Derivatives USD 597,000 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 859,000 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 21,000 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0001628280-23-007539
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap Depreciation Depreciation USD 1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.65M 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 0 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap DerivativeLiabilities Derivative Liability USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 73.34M 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.45 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001628280-21-009696
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.437 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.143 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Percent pure -0.079 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure -0.044 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.183 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.017 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.345 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.019 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0.001 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.266 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap EmbeddedDerivativeGainOnEmbeddedDerivative Embedded Derivative, Gain on Embedded Derivative USD 800,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 10.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 900,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014700
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 484,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 142.62M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 36.04M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 7.21M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015733
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 36.04M 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 36.04M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 214.71M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 72.08M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 31.94M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap Goodwill Goodwill USD 59.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2021-01-01 2021-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 115.50M 2020-04-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001628280-20-012337
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncentiveFromLessor Incentive from Lessor USD 3.29M 2018-04-30 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -3.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -31.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0001628280-23-007539
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 371,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -533,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -781,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationNondeductibleExpenseCharitableContributions Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount USD 294,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 165,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 680,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 18,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 988,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -7.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 7.28M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001564590-15-010025
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -10.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -28.10M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 671,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -139,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 976,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014700
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 188,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001564590-16-017968
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap IncreaseDecreaseInUnbilledReceivables Increase (Decrease) in Unbilled Receivables USD -33.54M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 234,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001564590-16-017968
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -10.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 6.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 18.18M 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 14.32M 2024-06-30 2024 Q2 10-Q 2024-08-08 0001628280-24-035879
us-gaap InventoryGross Inventory, Gross USD 235.18M 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap InventoryLIFOReservePeriodCharge Inventory, LIFO Reserve, Period Charge USD 1.58M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap InventoryNet Inventory, Net USD 18.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 48.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 1.88M 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 50,000 2026-06-30 2026 Q2 10-Q 2026-08-05 0001517022-26-000051
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 215.12M 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 2.64M 2023-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037557
us-gaap InventoryWriteDown Inventory Write-down USD 5.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.89M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 31,800 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 3.70M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 70,526 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 14.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 9.63M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.57M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.13M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 541,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 307,000 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 0 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 0 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 307,000 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 461,000 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028242
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 0 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 0 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 0 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 125,345 2013-12-31 2016 Q2 10-Q 2016-08-08 0001564590-16-023285
us-gaap Liabilities Liabilities USD 321.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 342.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LiabilitiesCurrent Liabilities, Current USD 162.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 45.93M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap LineOfCredit Long-term Line of Credit USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 40.00M 2019-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 15.00M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042962
us-gaap LongTermDebt Long-term Debt USD 50.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 37.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 50.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 1.59M 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 1.88M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 12.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -4.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 95.91M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -6.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 12.43M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -15.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -20.33M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -32.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -46.61M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045979
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -46.61M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045979
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD -575,964 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 193,114 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.60M 2020-10-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap OperatingExpenses Operating Expenses USD 132.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -22.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 10.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 930,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 9.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 9.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 4.20M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 46.87M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 6.78M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 129,000 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 5.35M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6.74M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 7.06M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 7.01M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 13.93M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010491
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 896,000 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 242,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012395
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 22,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020459
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.11 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 84.20M 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015733
us-gaap OtherAssetsCurrent Other Assets, Current USD 6.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 436,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 50.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax USD -56,358 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -56,358 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 225,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021255
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 795,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-28 0001628280-23-030698
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 72.08M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap OtherInventory Other Inventory, Gross USD 120.94M 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 897,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 153,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-08 0001564590-16-023285
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 3.30M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028242
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 10.36M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 162,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap PaymentsForRestructuring Payments for Restructuring USD 46,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001564590-15-006991
us-gaap PaymentsForRoyalties Payments for Royalties USD 2.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0001628280-25-012470
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.15M 2013-01-01 2013-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 172.44M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 4.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 24.29M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 25.38M 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap PostemploymentBenefitsLiabilityCurrent Postemployment Benefits Liability, Current USD 649,000 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015865
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 86.90M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 86.90M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0001628280-25-038600
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 3.95M 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 468.40M 2007-01-01 2018-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 41.24M 2013-01-01 2013-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 40.05M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014700
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 704.30M 2007-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 6.75M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 237,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005335
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 237,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 13.00M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028587
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 800,234 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 356,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -94.23M 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.53M 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 296,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 2.49M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 254,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001564590-15-010025
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 19,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 32.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 79.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 12.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 45.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 6.40M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap RestrictedCash Restricted Cash USD 904,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 904,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 14.70M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028242
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 300,000 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-021096
us-gaap RestructuringCharges Restructuring Charges USD 3.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RestructuringReserve Restructuring Reserve USD 1.01M 2023-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 3.20M 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.72B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 139.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 1.48M 2007-02-27 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap Revenues Revenues USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028609
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 9.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap SaleLeasebackTransactionMonthlyRentalPayments Sale Leaseback Transaction, Monthly Rental Payments USD 31,000 2013-12-01 2013-12-31 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap SecurityDeposit Security Deposit USD 179,130 2014-12-31 2016 Q2 10-Q 2016-08-08 0001564590-16-023285
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 82.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap SeveranceCosts1 Severance Costs USD 11.40M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028242
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 9.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.27 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-08-28 0001628280-23-030697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.3 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-193535
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.191 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.966 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 3.59M 2015-09-30 2015 Q3 10-Q 2015-11-09 0001564590-15-010025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.55M 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 657,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 11.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.14 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.13M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-28 0001628280-23-030698
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 6.35 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-28 0001628280-23-030698
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 746,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 20.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.46 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 8.76M 2016-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 3.69M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 18.15M 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 2.85 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 3.19M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 5.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ShortTermInvestments Short-term Investments USD 28.85M 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-303848
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 20.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.75 2014-03-05 2014-03-06 2017 FY 10-K 2018-03-12 0001564590-18-005286
us-gaap StockIssued1 Stock Issued USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 563,493 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 527.75M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003283
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 7.49M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 82,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 6.57M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015733
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 251,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 426,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004522
us-gaap StraightLineRent Straight Line Rent USD -3.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 86.90M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 157.83M 2013-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2014-12-31 2014 FY 10-K 2015-03-04 0001564590-15-001260
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 68,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2016-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 8,643 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-26 0001564590-19-009340
us-gaap TreasuryStockValue Treasury Stock, Value USD 162,000 2015-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 94,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 33.80M 2016-12-31 2016 FY 10-K 2017-03-06 0001564590-17-003466
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 281,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022727
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005286
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005286
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 184,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0001628280-24-011270
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 5.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 75.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 58.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 58.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 271.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 157.60M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015865
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 271.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001517022-26-000084
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001517022-26-000020

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →